» Articles » PMID: 22260319

Potential of Novel Mycobacterium Tuberculosis Infection Phase-dependent Antigens in the Diagnosis of TB Disease in a High Burden Setting

Abstract

Background: Confirming tuberculosis (TB) disease in suspects in resource limited settings is challenging and calls for the development of more suitable diagnostic tools. Different Mycobacterium tuberculosis (M.tb) infection phase-dependent antigens may be differentially recognized in infected and diseased individuals and therefore useful as diagnostic tools for differentiating between M.tb infection states. In this study, we assessed the diagnostic potential of 118 different M.tb infection phase-dependent antigens in TB patients and household contacts (HHCs) in a high-burden setting.

Methods: Antigens were evaluated using the 7-day whole blood culture technique in 23 pulmonary TB patients and in 19 to 21 HHCs (total n = 101), who were recruited from a high-TB incidence community in Cape Town, South Africa. Interferon-gamma (IFN-γ) levels in culture supernatants were determined by ELISA.

Results: Eight classical TB vaccine candidate antigens, 51 DosR regulon encoded antigens, 23 TB reactivation antigens, 5 TB resuscitation promoting factors (rpfs), 6 starvation and 24 other stress response-associated TB antigens were evaluated in the study. The most promising antigens for ascertaining active TB were the rpfs (Rv0867c, Rv2389c, Rv2450c, Rv1009 and Rv1884c), with Areas under the receiver operating characteristics curves (AUCs) between 0.72 and 0.80. A combination of M.tb specific ESAT-6/CFP-10 fusion protein, Rv2624c and Rv0867c accurately predicted 73% of the TB patients and 80% of the non-TB cases after cross validation.

Conclusions: IFN-γ responses to TB rpfs show promise as TB diagnostic candidates and should be evaluated further for discrimination between M.tb infection states.

Citing Articles

Diagnostic performance of biomarkers for differentiating active tuberculosis from latent tuberculosis: a systematic review and Bayesian network meta-analysis.

Jeong J, Shim S, Han S, Hwang I, Ihm C Front Microbiol. 2025; 15:1506127.

PMID: 39760075 PMC: 11695403. DOI: 10.3389/fmicb.2024.1506127.


Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB).

Richardson T, Smith B, Malherbe S, Shaw J, Noor F, MacDonald C BMC Infect Dis. 2023; 23(1):447.

PMID: 37400753 PMC: 10318779. DOI: 10.1186/s12879-023-08342-5.


Peptide microarray-based identification of dormancy-associated Mycobacterium tuberculosis antigens inducing immune responses among latent tuberculosis infection individuals in Thailand.

Hanthamrongwit J, Aruvornlop P, Saelee C, Wanta N, Poneksawat P, Soe P Sci Rep. 2023; 13(1):6978.

PMID: 37117690 PMC: 10141872. DOI: 10.1038/s41598-023-34307-4.


Use of DosR and Rpf antigens from Mycobacterium tuberculosis to screen for latent and relapse tuberculosis infection in a tuberculosis endemic community of Huainan City.

Mao L, Xu L, Wang X, Du J, Sun Q, Shi Z Eur J Clin Microbiol Infect Dis. 2022; 41(7):1039-1049.

PMID: 35612766 DOI: 10.1007/s10096-022-04459-8.


The Biological and Clinical Aspects of a Latent Tuberculosis Infection.

Khabibullina N, Kutuzova D, Burmistrova I, Lyadova I Trop Med Infect Dis. 2022; 7(3).

PMID: 35324595 PMC: 8955876. DOI: 10.3390/tropicalmed7030048.


References
1.
Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G . The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Cell Microbiol. 2007; 9(6):1455-65. DOI: 10.1111/j.1462-5822.2007.00884.x. View

2.
Zvi A, Ariel N, Fulkerson J, Sadoff J, Shafferman A . Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med Genomics. 2008; 1:18. PMC: 2442614. DOI: 10.1186/1755-8794-1-18. View

3.
Schuck S, Mueller H, Kunitz F, Neher A, Hoffmann H, Franken K . Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS One. 2009; 4(5):e5590. PMC: 2680040. DOI: 10.1371/journal.pone.0005590. View

4.
Wang L, Bai Y, Shi C, Gao H, Xue Y, Jiang H . Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice. APMIS. 2009; 116(12):1071-81. DOI: 10.1111/j.1600-0463.2008.01095.x. View

5.
Franken K, Hiemstra H, van Meijgaarden K, Subronto Y, den Hartigh J, Ottenhoff T . Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif. 2000; 18(1):95-9. DOI: 10.1006/prep.1999.1162. View